Riskified Raises 2026 Outlook Despite 6.75% Fall; Nayax Gains 0.17% on $350M Deal, Firefly Drops 2.74% on Wider Losses 

Mumbai, 12 November 2026: US stocks witnessed mixed trading on November 12, 2026, as investors assessed quarterly earnings, major corporate contracts, acquisitions and fresh capital-raising plans. Several companies reported strong revenue growth and raised financial forecasts, while others faced pressure from narrowing margins, earnings disappointments and funding requirements. Despite significant business wins, share price reactions remained uneven, highlighting investor focus on profitability, financial outlooks and execution risks across multiple sectors of the US market. 

Riskified Lifts 2026 Outlook, Shares Fall 6.75% Amid Gross Margin Concerns 

Riskified Ltd. (RSKD) raised its full-year 2026 revenue and adjusted EBITDA guidance following stronger-than-expected third-quarter results, as management highlighted accelerating merchant additions and growing adoption of its fraud prevention products. However, the earnings call also underscored pressure on gross margins as newly onboarded merchants typically carry higher chargeback ratios. 

Chief Financial Officer Aglika Dotcheva increased the company’s 2026 revenue guidance to $427 million-$433 million from the earlier $400 million-$410 million range. Adjusted EBITDA guidance was raised to $39 million-$43 million from $33 million-$39 million, implying a margin of approximately 10% at the midpoint. Management expects fourth-quarter revenue growth of approximately 29% at the midpoint. 

Digital finance emerged as a key growth driver, with billings from the category increasing more than 300% year over year. CEO Eido Gal attributed the expansion to new merchant additions and opportunities to cross-sell products and process higher transaction volumes. 

However, non-GAAP gross profit increased 20% to $49.7 million, while gross margin declined to 43% from 51% a year earlier. Gal attributed the pressure partly to higher initial chargeback ratios among newly onboarded merchants. The company raised its full-year gross profit growth outlook to 14%-16% from 11%-14%. 

Riskified also introduced Agent Identity Risk Intelligence to address fraud risks associated with AI-driven commerce. Meanwhile, adjusted EBITDA reached $8.1 million, and quarterly free cash flow stood at a record $15.2 million. 

Riskified shares were trading at $9.67, down 6.75%, as of 10:57:40 AM EST on November 12, 2026. The stock had closed at $10.37 previously and opened at $10.26. It recorded a high of $10.48 and a low of $9.66 during the session. 

Nayax Q3 EBITDA Jumps 32.9%, Shares Gain 0.17% as $350 Million IPS Deal Expands Parking Business 

Nayax Ltd. reported strong third-quarter 2026 results, with adjusted EBITDA growth outpacing revenue expansion, while completing its $350 million acquisition of IPS Group to strengthen its presence in the smart parking market. The company also raised its full-year 2026 financial guidance, incorporating contributions from the acquisition. 

Revenue increased 22.7% year over year to $128 million, compared with $104.3 million in the corresponding quarter last year. Adjusted EBITDA rose 32.9% to $24.2 million, with its margin expanding to 19% from 17%. Gross margin reached a record 49.6%, supported by a higher recurring revenue contribution, which accounted for 73% of total revenue. Transaction value increased 25.5% to $2.2 billion, while recurring revenue grew 21.3% to $93.5 million. 

The IPS Group acquisition, completed on October 1, 2026, for $350 million in cash, adds more than 250,000 managed parking spaces across the United States, United Kingdom, Ireland and Canada. IPS is expected to contribute over $90 million in 2026 revenue, with recurring revenue exceeding 60%. 

Nayax raised its 2026 revenue guidance to $530-$540 million from $510-$520 million and adjusted EBITDA guidance to $90-$95 million from $85-$90 million. It also outlined 2028 targets of $1 billion in revenue and a 30% adjusted EBITDA margin. 

Nayax shares traded at $53.09, up 0.17%, as of 11:09:07 AM EST on November 12, 2026. The previous close was $53, while the stock opened at $50.52 and recorded a high of $53.52 and a low of $50.52 during the session. 

Also Read: What Is the New York Stock Exchange (NYSE)?

Firefly Aerospace Q3 Loss Widens to $75.4 Million, Shares Decline 2.74% Despite 259% Revenue Growth 

Firefly Aerospace Inc. (FLY) reported a wider third-quarter 2026 net loss despite a sharp increase in revenue, as higher research and development spending and continued investments in next-generation launch vehicles weighed on profitability. The company posted a loss of $0.45 per share, significantly missing analysts’ expectations of a loss of $0.09 per share. 

Revenue surged 259% year over year to $110.7 million from $30.8 million in the corresponding quarter last year, marking the second consecutive quarter in which revenue exceeded $100 million. Spacecraft operations contributed $106 million, while launch services generated $4.7 million. Year-to-date revenue increased 203% to $309.2 million. 

Net loss widened to $75.4 million from $67.7 million in the second quarter of 2026, while operating loss increased to $78.7 million from $70.4 million. Adjusted EBITDA loss also widened to $69.5 million from $61.2 million. However, gross margin improved to 22.9% from 20.3% in the previous quarter. 

Firefly’s backlog reached a record $1.7 billion, supported by more than $300 million in new customer contracts during the quarter. The company also raised its 2026 revenue guidance to $440 million-$450 million from $420 million-$450 million. However, the Alpha Flight 8 launch was postponed to the first quarter of 2027. 

Firefly Aerospace shares were trading at $25.88, down 2.74%, as of 11:42:12 AM EST on November 12, 2026. The stock previously closed at $26.61 and opened at $26.18, recording a high of $26.99 and a low of $25.10 during the session. 

Boyd Group Q3 EPS Misses Estimates by 20%, Shares Decline 3.07% Despite 34% EBITDA Growth 

Boyd Group Services Inc. reported third-quarter 2026 adjusted earnings below analysts’ expectations, with adjusted earnings per share (EPS) of $0.68 against the consensus estimate of $0.85. Revenue also marginally missed estimates, although the company delivered strong year-over-year growth in revenue, gross profit and adjusted EBITDA. 

Revenue increased 28% year over year to approximately $1.01 billion, compared with the analyst estimate of $1.02 billion. Gross profit rose 29% to $473 million, while adjusted EBITDA increased 34% to $132 million. Adjusted EBITDA margin expanded to 13.0% from 12.4% in the corresponding quarter last year. Adjusted net earnings stood at $19 million, compared with $17.8 million a year earlier, while adjusted EPS declined from $0.83 to $0.68. 

Same-store sales increased 2.2%, outperforming the broader collision repair market, where repairable claims volumes declined an estimated 1%-3%. The company attributed its margin improvement to Project 360 savings, acquisition synergies and operational efficiencies. It had realised approximately $90 million in combined savings from Project 360 and Joe Hudson synergies through the first nine months of 2026. 

Management expects another $15 million in savings during the fourth quarter, taking the anticipated year-end total to $105 million. The longer-term savings target remains $140 million, with the remaining $35 million expected between 2027 and 2029. 

Boyd Group Services shares were trading at $74.81, down 3.07%, as of 11:56:52 AM EST on November 12, 2026. The previous close was $77.18, while the stock opened at $75.74 and recorded a high of $76.39 and a low of $74.57 during the session. 

SuperCom Q3 Revenue Beats Estimates by 4.2%, Shares Plunge 20.42% as Gross Margin Narrows 

SuperCom Ltd. (SPCB) reported a 21% year-over-year increase in third-quarter 2026 revenue, beating analysts’ expectations. However, shares declined sharply as lower gross margins, foreign exchange losses and a significant drop in GAAP net income weighed on investor sentiment. 

Revenue increased to $7.5 million from $6.2 million in the corresponding quarter last year, exceeding the analyst estimate of $7.2 million by approximately 4.2%. EBITDA rose 17% to $2.6 million from $2.2 million, while the EBITDA margin remained broadly stable at 34.4%, compared with 34.6% a year earlier. 

Despite the revenue growth, gross profit declined to $2.7 million from $3.8 million, while gross margin contracted to 49.8% from 60.8%. The company attributed pressure on profitability partly to a $1.3 million foreign exchange loss associated with the appreciation of the Israeli shekel. GAAP net income fell to $0.1 million from $0.7 million, while GAAP earnings per share declined to $0.01 from $0.14. Non-GAAP net income remained unchanged at $1.9 million. 

For the first nine months of 2026, revenue increased 14% to $23.2 million, while EBITDA climbed 37% to $9.9 million. SuperCom also highlighted expansion in its electronic monitoring business and introduced SafeGenie, a cybersecurity product designed to monitor and control autonomous AI agents. 

SuperCom shares were trading at $6.86, down 20.42%, as of 12:00:21 PM EST on November 12, 2026. The stock previously closed at $8.62 and opened at $8.51, reaching a high of $8.60 and a low of $6.49 during the session. 

Twist Bioscience Q4 Revenue Beats Estimates 2.4%, Shares Fall 9.87% Despite Guidance 

Twist Bioscience Corporation (NASDAQ: TWST) reported fourth-quarter fiscal 2026 results above analyst expectations, with revenue rising 28% year over year. However, its shares declined as investors assessed the company’s performance alongside its outlook for fiscal 2027. 

Revenue for the quarter reached $126.6 million, exceeding the consensus estimate of $123.59 million by approximately 2.4%. This compared with revenue of $99 million in the corresponding period last year. Adjusted earnings per share came in at a loss of $0.32, narrower than analysts’ expected loss of $0.38. 

The company recorded its 15th consecutive quarter of sequential revenue growth and reported positive adjusted EBITDA of $2.2 million, compared with negative $7.8 million a year earlier. 

For the first quarter of fiscal 2027, Twist expects revenue of $130 million to $132 million, with the midpoint of $131 million above the analyst consensus of $126.5 million. Its full-year fiscal 2027 revenue forecast stands at $550 million to $560 million, against a consensus estimate of $549.9 million. The company also expects gross margin of 52.5% to 53% and positive adjusted EBITDA for the full year. 

For fiscal 2026, revenue reached a record $459.4 million, up 22% from $376.6 million in fiscal 2025. Gross margin improved to 52.4% from 50.7%. DNA Synthesis and Protein Solutions revenue rose 32% to $221.9 million, while NGS Applications revenue increased 14% to $237.5 million. Twist ended the quarter with approximately $582 million in cash, cash equivalents and short-term investments. 

TWST traded at $110.49, down 9.87% as of 12:11:05 PM EST on November 12, 2026. The stock opened at $99.59, compared with the previous close of $122.59. It reached a high of $113.14 and a low of $93.85 during the session. 

Also Read: How to invest in US stocks

Cellebrite Q3 EPS Meets Estimates, Revenue Beats 2.35%, Shares Fall 7.40% Thursday 

Cellebrite DI Ltd. (NASDAQ: CLBT) reported third-quarter 2026 adjusted earnings in line with analyst expectations, while revenue exceeded consensus estimates. Despite the revenue beat, the company’s shares declined during Thursday’s trading session. 

The company posted adjusted earnings of $0.17 per share for the quarter ended September 2026, matching the Zacks Consensus Estimate. This compared with adjusted earnings of $0.14 per share in the year-ago period. In the previous quarter, Cellebrite reported earnings of $0.11 per share against expectations of $0.12, resulting in a negative earnings surprise of 8.33%. Over the past four quarters, the company has exceeded consensus earnings estimates once. 

Quarterly revenue reached $149.02 million, surpassing the Zacks Consensus Estimate by 2.35%. This represented an increase from $126.03 million in the corresponding period last year. Cellebrite has beaten revenue estimates in three of the past four quarters. 

Before the earnings announcement, the company’s estimate revisions trend was mixed, resulting in a Zacks Rank of #3 (Hold). The current consensus estimate for the coming quarter stands at earnings of $0.18 per share on revenue of $152.1 million. For the current fiscal year, analysts expect earnings of $0.57 per share and revenue of $557.12 million. 

Cellebrite shares have declined approximately 29.6% since the beginning of 2026, compared with an 11.3% gain for the S&P 500. 

CLBT traded at $11.76, down 7.40%, as of 12:23:22 PM EST on November 12, 2026. The stock opened at $13.37, against its previous close of $12.70. It reached a high of $13.65 and a low of $11.51 during the session. 

Intuitive Machines Q3 Revenue Hits $269.35 Million, Shares Rise 13.26% 

Intuitive Machines (NASDAQ: LUNR) reported better-than-expected third-quarter 2026 results on November 12, beating analyst estimates for both earnings and revenue. The company posted an adjusted loss of $0.02 per share, narrower than the analyst estimate of a $0.10 loss, representing a positive earnings surprise of $0.08. Revenue reached $269.35 million, exceeding the consensus estimate of $245.69 million. 

The company recorded quarterly revenue of approximately $269 million, up 31% sequentially, while gross profit increased to $69 million from $6 million a year earlier. Gross margin improved to 26% from 11%, although approximately $19 million of gross profit came from favourable one-time programme adjustments. Adjusted EBITDA turned positive at $8 million, compared with a loss of $13 million in the year-ago period. Free cash flow reached a record $33 million, while the company’s cash balance increased to $464 million. Its backlog also reached a record $1.9 billion. 

For FY2026, Intuitive Machines expects revenue between $920 million and $950 million, compared with its earlier outlook of $920 million to $940 million in the earnings summary and analyst consensus of $919.80 million. Management attributed the refinement of its revenue outlook to the timing of anticipated contract modifications and awards. 

Following the earnings announcement, Intuitive Machines shares were trading at $13.80, up $1.61 or 13.26% from the previous close of $12.18, as of 12:46:28 PM EST on November 12. The stock opened at $14.37 and recorded a high of $14.61 and a low of $13.56 during the session. 

Hancock Whitney to Acquire Trustmark for $3.2 Billion, Shares Decline 9.55% 

Hancock Whitney Corporation (NASDAQ: HWC) has agreed to acquire Trustmark Corporation in an all-stock transaction valued at approximately $3.2 billion, the companies announced on November 12, 2026. The proposed combination will create a bank with approximately $58 billion in assets and around 370 branches across six Southeastern US states. The transaction is expected to close in the first quarter of 2027, subject to customary closing conditions. 

Under the agreement, Hancock Whitney will issue 0.7463 shares of its common stock for each outstanding Trustmark share, representing a consideration of approximately $54.02 per share. Following completion, Hancock Whitney shareholders are expected to own approximately 65% of the combined company, while Trustmark shareholders will hold the remaining 35%. The combined institution is expected to have approximately $40 billion in gross loans and $48 billion in deposits. 

The acquisition is estimated to increase Hancock Whitney’s 2028 earnings per share by approximately 7%. The transaction is priced at 1.78 times tangible book value and is expected to result in 7% dilution to tangible book value per share, with an estimated earn-back period of approximately 2.8 years, including merger expenses. Five Trustmark board members, including its President and CEO Duane Dewey, will join Hancock Whitney’s board after the transaction closes. 

Following the announcement, Hancock Whitney shares were trading at $65.47, down $6.92 or 9.55% from the previous closing price of $72.38, as of 12:57:38 PM EST on November 12. The stock opened at $65.60 and recorded a high of $66.03 and a low of $63.27 during the session. 

Also Read: US Stock Market Timings

Virtuix Plans $12 Million STS Acquisition to Expand Defense Business, Shares Fall 1.64% 

Virtuix Holdings Inc. (NASDAQ: VTIX) has signed a non-binding letter of intent to acquire STS International Inc., an Arlington, Virginia-based defense technology and services company, for a base consideration of $12 million. Announced on November 12, 2026, the proposed transaction involves acquiring all outstanding equity interests of STS International on a debt-free, cash-free basis, using a combination of cash and equity. The agreement also includes potential earnout payments linked to contract awards and post-closing revenue targets. 

STS International reported approximately $40 million in unaudited cash-basis revenue for the 10 months ended October 31, 2026, compared with $6.7 million for the full 2025 calendar year. The company also reported positive EBITDA and year-to-date net income of approximately $0.6 million. Its capabilities include C5ISR, engineering, sustainment, training and simulation, serving defence and federal government markets. 

The proposed acquisition would establish Virtuix Defense, a new division aimed at expanding the company’s presence in the US defence market. STS International President David Morgan is expected to lead the division and join Virtuix’s board upon closing. The parties are targeting completion during Virtuix’s fiscal year ending March 31, 2027. However, the transaction remains subject to due diligence, financing, regulatory and other approvals. Virtuix has not secured committed financing for the cash consideration. 

Virtuix shares were trading at $0.6248, down $0.0104 or 1.64% from the previous close of $0.6352, as of 1:09:36 PM EST on November 12. The stock opened at $0.6371 and recorded a high of $0.6798 and a low of $0.5753 during the session. 

vVardis Cuts US IPO Size by 12%, Targets $200 Million Amid Market Volatility 

Swiss dental health company vVardis has reduced the size of its planned US initial public offering (IPO) by more than 12%, seeking to raise up to $200 million amid heightened market volatility and a technology stock selloff. According to a Reuters report published on November 12, 2026, the company now plans to offer 8.3 million shares at a price range of $21 to $24 apiece, compared with its earlier proposal to sell 9.5 million shares and raise up to $228.6 million. 

The IPO downsizing comes amid pressure on US equity markets following an AI-led technology selloff, concerns surrounding Nvidia’s market leadership and uncertainty over potential AI regulations and data centre spending. The timing also coincides with Anthropic beginning its roadshow for its anticipated IPO earlier in the week. 

Founded in 2020 by Swiss dentists and sisters Haley and Goly Abivardi, vVardis develops non-invasive dental treatments under its Curodont brand. Its products are designed to repair and reverse early-stage tooth decay without drilling or injections. The company achieved unicorn status in April 2026 following a minority investment from funds managed by Apollo Global Management. 

Goldman Sachs, J.P. Morgan, William Blair, UBS Investment Bank and Deutsche Bank Securities are underwriting the offering. vVardis plans to list its shares on the New York Stock Exchange under the ticker symbol VVVV. 

Keurig Dr Pepper Launches $2 Billion Stock Offering, Shares Decline 6.29% 

Keurig Dr Pepper Inc. (NASDAQ: KDP) announced on November 12, 2026, that it had launched an underwritten public offering of $2 billion worth of common stock. The company also intends to grant underwriters a 30-day option to purchase up to an additional $300 million in shares at the same offering price, subject to market conditions and customary closing requirements. 

The company plans to use the net proceeds to repay or repurchase approximately $2 billion of outstanding debt, accelerating its deleveraging strategy ahead of its previously announced separation into two independent, publicly traded businesses: Beverage Co. and Global Coffee Co. The separation is targeted for early 2027. According to the company, reducing debt is expected to strengthen the investment-grade credit profiles of both businesses and provide additional financial flexibility to pursue their respective strategic priorities. 

Goldman Sachs and Morgan Stanley are acting as joint book-running managers for the offering. 

Following the announcement, Keurig Dr Pepper shares were trading at $35.85, down $2.40 or 6.29% from the previous closing price of $38.25, as of 1:46:23 PM EST on November 12. The stock opened at $36.49 and recorded a high of $36.78 and a low of $35.71 during the session. 

CareTrust REIT Prices $637.5 Million Stock Offering, Shares Decline 1.10% 

CareTrust REIT, Inc. (NYSE: CTRE) announced on November 12, 2026, that it had priced an underwritten public offering of 17 million common shares, expected to generate approximately $637.5 million in gross proceeds. The underwriters have a 30-day option to purchase an additional 2.55 million shares, potentially increasing the total offering to 19.55 million shares. The offering is expected to close on November 13, subject to customary closing conditions. 

The transaction involves separate forward sale agreements with Bank of America and Morgan Stanley. Under these agreements, the forward purchasers or their affiliates are expected to borrow and sell the shares to underwriters. CareTrust REIT expects to physically settle the agreements within approximately one year, subject to its right to elect cash or net share settlement. The company will not initially receive proceeds from the shares sold by the forward purchasers. 

Upon settlement, the company intends to contribute the net proceeds to its operating subsidiary, CTR Partnership, L.P., for general corporate purposes, including potential acquisitions, investments or debt repayment. BofA Securities, Morgan Stanley, J.P. Morgan and Wells Fargo Securities acted as book-running managers. 

Following the announcement, CareTrust REIT shares traded at $38.19, down $0.42 or 1.10% from the previous close of $38.61, as of 1:52:22 PM EST on November 12. The stock opened at $37.70 and recorded a high of $38.19 and a low of $37.53 during the session. 

PepGen Prices $125 Million Stock Offering, Shares Decline 4.66% 

PepGen Inc. (NASDAQ: PEPG), a clinical-stage biotechnology company developing oligonucleotide therapies for rare genetic diseases, announced the pricing of a $125 million public offering on November 12, 2026. The company is offering 25 million shares of common stock at $5 per share, with gross proceeds expected to reach $125 million before underwriting discounts, commissions and offering expenses. 

PepGen has also granted underwriters a 30-day option to purchase up to an additional 3.75 million shares at the offering price, less applicable underwriting discounts and commissions. If fully exercised, the additional shares would increase the total offering size to 28.75 million shares. The offering is expected to close on or about November 13, subject to customary closing conditions. 

The company intends to use the net proceeds to fund the ongoing clinical development of its product candidate, along with working capital and other general corporate purposes. Leerink Partners, Stifel and Guggenheim Securities are acting as joint book-running managers, while Oppenheimer & Co. and H.C. Wainwright & Co. are serving as passive bookrunner and lead manager, respectively. 

PepGen shares were trading at $5.02, down $0.25 or 4.66% from the previous close of $5.26, as of 1:56:39 PM EST on November 12. The stock opened at $5.26 and recorded a high of $5.34 and a low of $4.84 during the session. 

Also Read: What Are Fractional Shares? 

Southern Company Plans $1.75 Billion Equity Units Offering, Shares Decline 0.77% 

Southern Company (NYSE: SO) announced plans to offer 35 million equity units at a stated amount of $50 each, representing an aggregate stated value of $1.75 billion. Each unit will comprise a contract to purchase the company’s common stock in the future and two 1/40 beneficial ownership interests in remarketable senior notes, each with a $1,000 principal amount. 

The company expects to grant underwriters an option to purchase an additional 5 million units, worth $250 million, to cover over-allotments. Proceeds will partly fund repurchases of its 4.50% Convertible Senior Notes due June 2027. Remaining funds will go towards short-term debt repayment and general corporate purposes, including subsidiary investments. BofA Securities and Barclays will lead the offering. 

Southern Company shares traded at $93.12, down $0.72 or 0.77% from the previous close of $93.84, as of 1:57:55 PM EST. The stock opened at $93.54 and recorded a session high of $94.17 and low of $92.80. 

Fermi Jumps 17.5% on $200M Deal as Elbit Gains 2.1% on $260M NATO Contract, AeroVironment Falls 2.7% 

Elbit Systems (ESLT) shares rose 2.1% to about $740.50 by mid-session (previous close $725.44) after the company won a ~$260 million NATO contract to supply PULS rocket artillery systems and munitions to an undisclosed European member. The material backlog addition reinforced Elbit’s position as a key Western defense supplier amid sustained European demand. 

Allison Transmission (ALSN) gained 3.6% to roughly $130.09 after securing a $67 million U.S. Army contract to continue supporting the Abrams Main Battle Tank program with its X1100 cross-drive transmission. The recurring defense award provided revenue visibility for Allison’s defense segment. Parsons (PSN) fell 2.4% to a range of $49.35–$50.57 despite receiving a contract amendment worth up to $100 million for environmental remediation engineering on the US west coast. The decline appeared tied to broader market weakness rather than the contract, which added meaningful backlog. 

Fermi (FRMI) jumped 17.5% to $1.81 after announcing a ~$200 million prepayment from an investment-grade hyperscaler to advance 600 MW of power capacity at Project Matador, plus a $15 million early construction agreement and a contemplated $90 million steel purchase. For a pre-revenue company, the customer capital commitment materially de-risked the project. 

HawkEye 360 (HAWK) disclosed in an 8-K ~$135 million in new global contracts signed since October 1, including over $70 million in European awards; pricing data was unavailable at mid-session. AeroVironment (AVAV) fell 2.7% to about $122.24–$124.40 even after securing a $405 million international order for LOCUST X3 laser weapon systems in the Middle East. The negative move could not be clearly attributed to the contract and likely reflected sector pressure. 

Intuitive Machines (LUNR) rose 3.1% to $12.18, fading a 13% premarket spike, after reporting record Q3 2026 results and confirming its selection as a vendor for NASA’s $10 billion CLPS 2 lunar contract. 

The latest market developments reflected mixed investor sentiment, with strong earnings, major contracts and acquisitions failing to consistently lift share prices. While Fermi and Intuitive Machines gained on significant business developments, SuperCom, Twist Bioscience and Cellebrite declined despite revenue growth or earnings beats. Margin pressures, funding requirements, earnings misses and broader market uncertainty remained key factors influencing stock performance. 

Source 

• https://www.nasdaq.com/ 

• spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.dowjones.com/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-industrial-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.nasdaq.com/market-activity/index/comp 

• https://www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index 

• https://www.spglobal.com/spdji/en/indices/equity/sp-100/ 

• https://www.lseg.com/en/ftse-russell/indices/russell-us 

• https://www.nyse.com/index 

• https://www.nyse.com/index 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-transportation-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-utility-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-composite-average/ 

• https://www.nasdaq.com/market-activity/index/sox 

• https://www.cboe.com/tradable_products/vix/